Cas No 35607-66-0 Cefoxitin antibiotic API β lactam cephalosporin antibiotics second generation cephamycins

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Your demand
Delivery Time: Negotiation
Payment Terms: D/P, D/A, L/C, T/T
Supply Ability: Negotiation
Cas No: 35607-66-0 Ec No: 252-641-2
Name: Cefoxitin Synonyms: Cfx;CEFOXITIN;Mefoxin
Molecular Formula: C16H17N3O7S2 Molecular Weight: 427.45
Melting Point: 149-150℃ Boiling Point: 843℃
Solubility: Predicted Solubility In Water Is Less Than 0.2mg/ml Density: 1.444 G/cm3
Risk Codes: N/A Safety Description: N/A
High Light:

Cas No 35607-66-0


35607-66-0 Cefoxitin antibiotic API


Cas number 35607-66-0

Cefoxitin Cas No 35607-66-0 API; Anti-biotic; β -lactam, cephalosporin antibiotics


Name Cefoxitin
Synonyms cfx;CEFOXITIN;Mefoxin
Molecular Formula C16H17N3O7S2
Molecular Weight 427.45
CAS Registry Number 35607-66-0
EINECS Number 252-641-2
Melting point 149-150
Boiling point 843
Solubility Predicted solubility in water is less than 0.2mg/ml
Density 1.444 g/cm3
Safety Description N/A
Risk Codes N/A

Product Description:


Cefoxitin is a β-lactam, cephalosporin antibiotic, with bactericidal activity. It is a new antibiotic produced by Streptomyces cephalosin, which is semi-synthetic. Its parent nucleus is similar to cephalosporins and has similar antimicrobial properties, so it is traditionally included in the second generation cephalosporins.


Product Use:


Cefoxitin has good activity against Gram-positive bacteria. The MICs for several Gram-positive pathogens are in the range of 1-6 μg/mL.


Cas No 35607-66-0 Cefoxitin antibiotic API β lactam cephalosporin antibiotics second generation cephamycins 0Cas No 35607-66-0 Cefoxitin antibiotic API β lactam cephalosporin antibiotics second generation cephamycins 1

Product Catalogue:

Number Cas Name
1 61336-70-7 Amoxicillin Trihydrate
2 7177-48-2 Ampicillin Trihydrate
3 79350-37-1 Cefixime
4 92665-29-7 Cefprozil
5 91832-40-5 Cefdinir
6 64485-93-4 Cefotaxime Sodium
7 74578-69-1 Ceftriaxone Sodium
8 15686-71-2 Cephalexin
9 53994-73-3 Cefaclor
10 35607-66-0 Cefoxitin
11 55268-75-2 Cefuroxime
12 86393-32-0 Ciprofloxacin Hydrochloride
13 93106-60-6 Enrofloxacin
14 112811-59-3 Gatifloxacin
15 100986-85-42 Levofloxacin
16 138199-71-0 Levofloxacin Hydrochloride
17 115550-35-1 Marbofloxacin
18 124858-35-1 Nadifloxacin
19 82419-36-1 Ofloxacin
20 136905-87-8 Pazufloxacin mesilate
21 108138-46-1 Tosufloxacin


About us



Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.


Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486